Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
Effects of Fresh Mango as a Sugar Substitute Within High and Low Glycemic Breakfasts on Postprandial Glucose and Insulin
1 other identifier
interventional
24
1 country
1
Brief Summary
Large blood sugar and insulin increases after meals high in table sugar are related to risk for diabetes and heart disease. Additionally, large increases in blood sugar may also negatively impact vascular health. Previous research suggests that mango consumed in small quantities has blood sugar-lowering properties, but the evidence of this within larger, more realistic meals is limited. The investigators want to understand if replacing table sugar (sucrose) with sugar from fresh mango (which also contains fiber and plant bioactives) will lead to more favorable blood sugar, insulin, and vascular responses after eating breakfast meals. The investigators will compare the postprandial glycemic, insulinemic, and vascular response to low and high glycemic meals sweetened with either fresh mango or sucrose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 26, 2025
CompletedFirst Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 1, 2025
June 1, 2025
1.7 years
June 24, 2025
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Glucose
The investigators will measure glucose at baseline and .5-, 1-, 2-, and 3-hours after each meal. These measurements will take place immediately and a complete dataset will be compiled upon study completion.
Through study completion, up to 1.5 years.
Insulin
The investigators will measure insulin at baseline and .5- 1-, 2-, and 3-hours after each meal containing. These measurements will take place immediately and a complete dataset will be compiled upon study completion.
Through study completion, up to 1.5 years.
Flow-mediated Dilation
The investigators will measure FMD at baseline and 1-, 2-, and 3-hours after the meal. These measurements will take place immediately and a complete dataset will be compiled upon study completion.
Through study completion, up to 1 year.
Secondary Outcomes (4)
HDL-C
Through study completion, up to 1 year.
Triglycerides
Through study completion, up to 1 year.
Acceptability
Through study completion, up to 1 year.
Satiety
Through study completion, up to 1 year.
Other Outcomes (2)
Body Composition
Through study completion, up to 1 year.
Systolic and Diastolic Pressure
Through study completion, up to 1 year.
Study Arms (4)
Cereal Consumption with Mango
EXPERIMENTALDuring the Cereal and Mango arm, participants will consume a bowl of corn flakes with 2% milk sweetened with fresh mango.
Cereal Consumption with Table Sugar
EXPERIMENTALDuring the Cereal and Table Sugar arm, participants will consume a bowl of corn flakes with 2% milk sweetened with table sugar.
Oat Consumption with Mango
EXPERIMENTALDuring the Oats and Mango Arm, participants will consume a bowl of oats prepared with water and sweetened with fresh mango.
Oat Consumption with Table Sugar
EXPERIMENTALDuring the Oat and Table Sugar arm, participants will consume a bowl of oats prepared with water and sweetened with table sugar.
Interventions
Low-glycemic breakfast of 80 grams of oats prepared with 473mL water and sweetened with 146 grams of mango.
High-glycemic breakfast of 84 grams of corn flakes prepared with 355mL of 2% milk and sweetened with 262 grams of mango.
Low-glycemic breakfast of 80 grams of oats prepared with 473mL of water and sweetened with 20 grams of table sugar.
High-glycemic breakfast of 84 grams of corn flakes prepared with 355mL of 2% milk and sweetened with 36 grams of table sugar.
Eligibility Criteria
You may qualify if:
- years.
- Body mass index between 18.5-35.0 kg/m2
- Not pregnant (females only)
- Not postmenopausal (females only).
- Not been diagnosed with cardiovascular disease.
- Not been diagnosed with a cardiometabolic conditions (e.g., type 2 diabetes)
- Not been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
- Does not regularly take anti-inflammatory drugs (more than 2x week).
- Does not use glucose-lowering drugs (e.g., metformin)
- Does not use lipid-lowering drugs (e.g., statins)
- Does not use tobacco products or any illicit drugs.
- Does not have a pacemaker.
- Can consume mango, wheat, gluten, and milk.
- Can stay in a supine position in the dark for at least ten minutes.
You may not qualify if:
- Not between the ages of 18-45
- Body mass index \< 18.5 kg/m2 or \>35.0 kg/m2
- Pregnant (females only)
- Postmenopausal status (females only).
- Been diagnosed with cardiovascular disease.
- Been diagnosed with a cardiometabolic conditions (e.g., type 2 diabetes)
- Been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
- Regularly take anti-inflammatory drugs (more than 2x week).
- Uses glucose-lowering drugs (e.g., metformin)
- Uses lipid-lowering drugs (e.g., statins)
- Uses tobacco products or any illicit drugs.
- Have a pacemaker.
- Allergic to mango, wheat, gluten, and/or milk.
- Unable to lay in supine position in the dark for at least ten minutes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ball State Universitylead
- National Mango Boardcollaborator
Study Sites (1)
Health Professions Building, Ball State University
Muncie, Indiana, 47306, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bryant Keirns, PhD
Ball State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 1, 2025
Study Start
March 26, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 1, 2025
Record last verified: 2025-06